Calcium [EPC]

Calcium [EPC] was reported 149695 times

Drugs of the Calcium [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 DEEP VEIN THROMBOSIS POSTOPERATIVE 655 0.3270
1 LUPUS VULGARIS 392 0.3111
2 C-REACTIVE PROTEIN 264 0.2848
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 182 0.2725
4 SWOLLEN JOINT COUNT INCREASED 750 0.2350
5 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 471 0.2271
6 BLOOD PRESSURE DIASTOLIC ABNORMAL 578 0.2270
7 BLOOD PRESSURE SYSTOLIC ABNORMAL 544 0.2199
8 RECALLED PRODUCT 373 0.2154
9 RHEUMATIC FEVER 922 0.2066
10 DISLOCATION OF VERTEBRA 470 0.2059
11 X-RAY ABNORMAL 314 0.1754
12 RETINITIS 288 0.1666
13 FACET JOINT SYNDROME 514 0.1577
14 RHEUMATOID FACTOR POSITIVE 871 0.1506
15 DUODENAL ULCER PERFORATION 1057 0.1420
16 NASAL OEDEMA 256 0.1416
17 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 982 0.1369
18 SERONEGATIVE ARTHRITIS 150 0.1309
19 BONE EROSION 424 0.1198
20 PEMPHIGUS 1433 0.1145
21 PERIPHERAL VENOUS DISEASE 467 0.1142
22 HELICOBACTER INFECTION 1127 0.1095
23 MUSCLE INJURY 857 0.1033
24 HAND DEFORMITY 1332 0.1015
25 BLOOD CALCIUM INCREASED 861 0.0981
26 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 634 0.0975
27 C-REACTIVE PROTEIN ABNORMAL 604 0.0941
28 PORPHYRIA ACUTE 123 0.0857
29 FOLLICULITIS 894 0.0852
30 OBSTRUCTIVE SLEEP APNOEA SYNDROME 114 0.0781
31 BLOOD CALCIUM ABNORMAL 130 0.0781
32 DRUG TOLERANCE DECREASED 217 0.0772
33 SYNOVITIS 1382 0.0766
34 BREAST CANCER STAGE III 496 0.0765
35 LIP DRY 688 0.0757
36 KYPHOSIS 132 0.0746
37 AUTOIMMUNE DISORDER 722 0.0740
38 EXOSTOSIS 676 0.0740
39 JOINT RANGE OF MOTION DECREASED 974 0.0726
40 HYPERCHOLESTEROLAEMIA 701 0.0725
41 SCIATICA 1146 0.0718
42 BLOOD PRESSURE DIASTOLIC DECREASED 526 0.0712
43 GLOSSODYNIA 1588 0.0709
44 PERICARDITIS 1187 0.0706
45 WOUND INFECTION 773 0.0705
46 BURSITIS 832 0.0685
47 GRIP STRENGTH DECREASED 603 0.0684
48 WALKING AID USER 429 0.0650
49 MUSCLE CRAMP 114 0.0642
50 FIBROMYALGIA 1548 0.0636
51 BLOOD PRESSURE DIASTOLIC INCREASED 293 0.0634
52 BLOOD PRESSURE SYSTOLIC INCREASED 1164 0.0596
53 BLOOD CALCIUM DECREASED 670 0.0595
54 WOUND 1637 0.0585
55 BLEPHAROSPASM 362 0.0574
56 LIVER INJURY 1404 0.0571
57 HYPOCALCAEMIA 1070 0.0565
58 THORACIC VERTEBRAL FRACTURE 164 0.0554
59 LUMBAR VERTEBRAL FRACTURE 249 0.0543
60 HYPERPHOSPHATAEMIA 116 0.0539
61 FOOT DEFORMITY 598 0.0539
62 LIVE BIRTH 449 0.0536
63 LOWER LIMB FRACTURE 1027 0.0534
64 IRRITABLE BOWEL SYNDROME 1101 0.0513
65 OSTEOPENIA 772 0.0508
66 HYPERTONIC BLADDER 146 0.0505
67 OSTEOARTHRITIS 2141 0.0505
68 BONE DENSITY ABNORMAL 188 0.0503
69 BLOOD PRESSURE FLUCTUATION 1197 0.0498
70 BODY TEMPERATURE DECREASED 487 0.0494
71 HYPERCALCAEMIA 588 0.0476
72 RESPIRATORY SYMPTOM 135 0.0474
73 JOINT DISLOCATION 501 0.0473
74 THERAPEUTIC REACTION TIME DECREASED 138 0.0473
75 PATHOLOGICAL FRACTURE 238 0.0469
76 VITAMIN D DECREASED 399 0.0466
77 BODY HEIGHT DECREASED 494 0.0462
78 PULMONARY FIBROSIS 884 0.0460
79 PLANTAR FASCIITIS 154 0.0459
80 OSTEOPOROSIS 1886 0.0458
81 IMPAIRED HEALING 1477 0.0449
82 SYSTEMIC LUPUS ERYTHEMATOSUS 1581 0.0445
83 RED BLOOD CELL SEDIMENTATION RATE INCREASED 492 0.0444
84 NAIL DISORDER 386 0.0441
85 LOOSE TOOTH 142 0.0440
86 ARTHROPATHY 2449 0.0440
87 HIP ARTHROPLASTY 663 0.0432
88 ATYPICAL FEMUR FRACTURE 120 0.0425
89 PSORIATIC ARTHROPATHY 1718 0.0423
90 STRESS FRACTURE 226 0.0418
91 COMPRESSION FRACTURE 221 0.0412
92 TYPE 2 DIABETES MELLITUS 1388 0.0412
93 BLOOD CHOLESTEROL INCREASED 1914 0.0410
94 FAECAL CALPROTECTIN INCREASED 130 0.0410
95 CHRONIC SINUSITIS 153 0.0407
96 ULCER HAEMORRHAGE 275 0.0406
97 PRESCRIBED OVERDOSE 786 0.0406
98 LUMBAR SPINAL STENOSIS 117 0.0400
99 LUPUS-LIKE SYNDROME 358 0.0394
100 PELVIC FRACTURE 304 0.0390
101 SPINAL COMPRESSION FRACTURE 321 0.0388
102 BLOOD PARATHYROID HORMONE INCREASED 113 0.0388
103 MUCOUS STOOLS 186 0.0375
104 FINGER DEFORMITY 181 0.0373
105 IRON DEFICIENCY 168 0.0373
106 CONTRAINDICATED PRODUCT ADMINISTERED 1129 0.0373
107 BRAIN NATRIURETIC PEPTIDE INCREASED 114 0.0369
108 BONE LESION 133 0.0368
109 WHEEZING 2184 0.0368
110 WRIST FRACTURE 434 0.0362
111 BONE DISORDER 659 0.0361
112 KNEE ARTHROPLASTY 761 0.0361
113 SPONDYLITIS 131 0.0360
114 OEDEMA 1932 0.0356
115 SPINAL FRACTURE 713 0.0355
116 OBESITY 565 0.0354
117 GAIT INABILITY 1181 0.0353
118 SPINAL OSTEOARTHRITIS 310 0.0353
119 ONYCHOCLASIS 242 0.0351
120 MUSCULOSKELETAL PAIN 1823 0.0348
121 FAECES SOFT 252 0.0346
122 MOBILITY DECREASED 2487 0.0346
123 INTERVERTEBRAL DISC DEGENERATION 319 0.0344
124 HEART RATE DECREASED 1203 0.0342
125 RIB FRACTURE 691 0.0336
126 NIGHT SWEATS 1077 0.0334
127 BONE PAIN 1954 0.0333
128 POOR VENOUS ACCESS 345 0.0333
129 MATERNAL EXPOSURE TIMING UNSPECIFIED 125 0.0332
130 TOOTH FRACTURE 365 0.0331
131 ANAL FISSURE 177 0.0330
132 SPINAL COLUMN STENOSIS 155 0.0328
133 FOOT FRACTURE 622 0.0328
134 SYNOVIAL CYST 151 0.0327
135 GROIN PAIN 287 0.0326
136 TIBIA FRACTURE 153 0.0326
137 ONYCHOMYCOSIS 143 0.0326
138 ONYCHOMADESIS 136 0.0324
139 FAECES HARD 126 0.0323
140 SPINAL FUSION SURGERY 131 0.0323
141 GINGIVAL PAIN 256 0.0321
142 JAW DISORDER 176 0.0321
143 PRESCRIBED UNDERDOSE 640 0.0320
144 FREQUENT BOWEL MOVEMENTS 864 0.0320
145 JOINT STIFFNESS 838 0.0319
146 PAIN IN JAW 903 0.0318
147 TRIGGER FINGER 130 0.0318
148 INFUSION RELATED REACTION 2107 0.0318
149 OBSTRUCTIVE AIRWAYS DISORDER 350 0.0314
150 APHTHOUS ULCER 244 0.0314
151 EAR PAIN 606 0.0311
152 BLOOD MAGNESIUM DECREASED 268 0.0310
153 DRUG LEVEL BELOW THERAPEUTIC 171 0.0310
154 TOOTH DISORDER 689 0.0310
155 BLOOD IRON DECREASED 367 0.0309
156 SCOLIOSIS 191 0.0308
157 VITAMIN D DEFICIENCY 300 0.0307
158 RHEUMATOID ARTHRITIS 3457 0.0304
159 COLITIS MICROSCOPIC 144 0.0304
160 BLISTER 1679 0.0299
161 RENAL CYST 237 0.0298
162 SKIN ABRASION 141 0.0298
163 DEFAECATION URGENCY 209 0.0298
164 HYPERKERATOSIS 164 0.0297
165 MUSCULOSKELETAL STIFFNESS 2600 0.0296
166 MICTURITION URGENCY 339 0.0296
167 DISCOMFORT 1808 0.0296
168 SPINAL STENOSIS 122 0.0295
169 BLOOD PRESSURE SYSTOLIC DECREASED 134 0.0294
170 RALES 171 0.0294
171 STOMATITIS 1781 0.0293
172 MUSCULOSKELETAL CHEST PAIN 454 0.0293
173 SPUTUM DISCOLOURED 277 0.0292
174 TASTE DISORDER 585 0.0288
175 TOOTH ABSCESS 292 0.0286
176 INFUSION SITE SWELLING 180 0.0286
177 TOOTH INFECTION 375 0.0284
178 SINUSITIS 2903 0.0283
179 DENTAL CARIES 311 0.0281
180 GINGIVAL DISORDER 108 0.0281
181 INCREASED UPPER AIRWAY SECRETION 144 0.0280
182 TOOTHACHE 506 0.0279
183 SPINAL PAIN 326 0.0278
184 CONTUSION 2674 0.0277
185 ARTHRITIS 2184 0.0277
186 HEPATIC ENZYME INCREASED 1889 0.0277
187 UPPER LIMB FRACTURE 552 0.0277
188 EAR INFECTION 732 0.0275
189 HEPATIC CIRRHOSIS 516 0.0274
190 INTENTIONAL PRODUCT USE ISSUE 2405 0.0274
191 SEASONAL ALLERGY 388 0.0274
192 BREATH SOUNDS ABNORMAL 135 0.0274
193 HUMERUS FRACTURE 132 0.0273
194 JOINT SWELLING 3296 0.0273
195 WEIGHT FLUCTUATION 284 0.0271
196 POSTOPERATIVE WOUND INFECTION 183 0.0271
197 BLOOD CHOLESTEROL ABNORMAL 125 0.0270
198 LYMPHOEDEMA 187 0.0270
199 MENISCUS INJURY 166 0.0270
200 LOWER RESPIRATORY TRACT INFECTION 1226 0.0269
201 UPPER-AIRWAY COUGH SYNDROME 222 0.0269
202 RESPIRATORY TRACT INFECTION 701 0.0269
203 LIGAMENT SPRAIN 266 0.0269
204 DIVERTICULUM 191 0.0269
205 NERVE COMPRESSION 247 0.0267
206 BREAST CANCER STAGE II 222 0.0267
207 CARPAL TUNNEL SYNDROME 372 0.0265
208 BONE DENSITY DECREASED 829 0.0264
209 URINE ABNORMALITY 120 0.0264
210 HYPOPHOSPHATAEMIA 195 0.0264
211 NODULE 344 0.0263
212 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 450 0.0262
213 C-REACTIVE PROTEIN INCREASED 952 0.0261
214 MACULAR DEGENERATION 311 0.0260
215 APLASTIC ANAEMIA 136 0.0260
216 NOCTURIA 315 0.0259
217 INFLAMMATION 1338 0.0259
218 JOINT EFFUSION 178 0.0258
219 GINGIVAL SWELLING 114 0.0258
220 ROAD TRAFFIC ACCIDENT 1078 0.0257
221 SPINAL DISORDER 242 0.0255
222 MULTIPLE ALLERGIES 200 0.0255
223 SWELLING 2381 0.0254
224 HIATUS HERNIA 329 0.0254
225 PROSTATIC SPECIFIC ANTIGEN INCREASED 350 0.0254
226 GINGIVITIS 137 0.0254
227 THYROID DISORDER 391 0.0253
228 FEMUR FRACTURE 783 0.0253
229 HEART RATE IRREGULAR 571 0.0252
230 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 428 0.0252
231 DRUG LEVEL DECREASED 256 0.0251
232 BACK DISORDER 408 0.0251
233 DIVERTICULITIS 694 0.0250
234 SECRETION DISCHARGE 313 0.0250
235 BOWEL MOVEMENT IRREGULARITY 191 0.0249
236 CYSTITIS 793 0.0249
237 ORAL PAIN 557 0.0249
238 HIP FRACTURE 799 0.0248
239 LUNG DISORDER 1214 0.0247
240 LARGE INTESTINE POLYP 171 0.0247
241 SINUS CONGESTION 331 0.0245
242 DRY MOUTH 1987 0.0245
243 CLOSTRIDIUM DIFFICILE INFECTION 534 0.0244
244 ROTATOR CUFF SYNDROME 314 0.0244
245 ANKLE FRACTURE 378 0.0244
246 HAND FRACTURE 173 0.0244
247 BLOOD TEST ABNORMAL 343 0.0244
248 TUMOUR MARKER INCREASED 117 0.0244
249 SENSITIVITY TO WEATHER CHANGE 128 0.0243
250 EXERCISE TOLERANCE DECREASED 140 0.0243
251 MUSCULOSKELETAL DISCOMFORT 417 0.0242
252 BRONCHITIS 1791 0.0242
253 ARTHRALGIA 10053 0.0242
254 URINE ODOUR ABNORMAL 142 0.0241
255 HYPOAESTHESIA 3614 0.0241
256 PAIN IN EXTREMITY 7113 0.0241
257 COLITIS ULCERATIVE 1078 0.0241
258 THERAPEUTIC PRODUCT EFFECT DECREASED 1079 0.0241
259 INCREASED TENDENCY TO BRUISE 221 0.0240
260 NEPHROGENIC ANAEMIA 111 0.0239
261 TOOTH EXTRACTION 298 0.0239
262 GASTROOESOPHAGEAL REFLUX DISEASE 1923 0.0239
263 NECK PAIN 1332 0.0238
264 ABNORMAL FAECES 195 0.0238
265 NASOPHARYNGITIS 4364 0.0237
266 CATARACT 1409 0.0236
267 GASTROINTESTINAL INFLAMMATION 185 0.0236
268 HOT FLUSH 1779 0.0236
269 POLYARTHRITIS 124 0.0235
270 ASTHMA 2655 0.0235
271 PULMONARY MASS 349 0.0234
272 GASTROINTESTINAL SOUNDS ABNORMAL 116 0.0234
273 CYST 290 0.0233
274 LOCALISED INFECTION 565 0.0233
275 DYSLIPIDAEMIA 118 0.0232
276 HEART RATE ABNORMAL 129 0.0231
277 PERIPHERAL SWELLING 3556 0.0231
278 BRONCHIECTASIS 155 0.0230
279 MUSCLE SPASMS 4203 0.0229
280 PRODUCTIVE COUGH 1093 0.0229
281 RESPIRATORY RATE INCREASED 203 0.0228
282 ARTHROPOD BITE 169 0.0228
283 HAIR TEXTURE ABNORMAL 305 0.0228
284 MASS 318 0.0227
285 DYSPEPSIA 2238 0.0227
286 SLEEP DISORDER 1605 0.0227
287 INTERVERTEBRAL DISC PROTRUSION 496 0.0227
288 OSTEONECROSIS OF JAW 561 0.0226
289 BLOOD PRESSURE INCREASED 3446 0.0225
290 SKIN LACERATION 245 0.0225
291 EYE INFECTION 254 0.0225
292 UPPER RESPIRATORY TRACT INFECTION 1039 0.0225
293 BACK PAIN 5212 0.0224
294 DYSPNOEA EXERTIONAL 844 0.0224
295 DRUG INTOLERANCE 2159 0.0223
296 INFUSION SITE EXTRAVASATION 139 0.0223
297 FULL BLOOD COUNT ABNORMAL 236 0.0223
298 SENSATION OF FOREIGN BODY 188 0.0223
299 JOINT INJURY 476 0.0223
300 ABDOMINAL DISCOMFORT 3734 0.0222
301 ALOPECIA 4368 0.0222
302 POLYP 145 0.0221
303 PERIPHERAL VASCULAR DISORDER 114 0.0221
304 VARICOSE VEIN 114 0.0221
305 HAIR GROWTH ABNORMAL 152 0.0219
306 MUSCULAR WEAKNESS 2495 0.0219
307 LIMB INJURY 595 0.0219
308 RED BLOOD CELL COUNT DECREASED 626 0.0219
309 ARTERIOSCLEROSIS 206 0.0219
310 SINUS DISORDER 433 0.0218
311 GAIT DISTURBANCE 4176 0.0218
312 CATARACT OPERATION 129 0.0217
313 DECREASED IMMUNE RESPONSIVENESS 213 0.0217
314 HAEMATOCHEZIA 1197 0.0217
315 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1039 0.0216
316 DYSSTASIA 631 0.0216
317 GLAUCOMA 416 0.0216
318 HAEMORRHOIDS 421 0.0216
319 ORAL DISORDER 158 0.0215
320 PARAESTHESIA ORAL 310 0.0215
321 PROCTALGIA 138 0.0214
322 FEMORAL NECK FRACTURE 110 0.0214
323 BREAST MASS 144 0.0214
324 BLOOD POTASSIUM DECREASED 644 0.0214
325 METASTASES TO BONE 349 0.0212
326 OXYGEN SATURATION DECREASED 1194 0.0212
327 DIZZINESS POSTURAL 206 0.0212
328 SKIN ATROPHY 122 0.0212
329 FACIAL PAIN 189 0.0212
330 ANAL INCONTINENCE 190 0.0211
331 LIMB DISCOMFORT 653 0.0211
332 GASTROINTESTINAL INFECTION 189 0.0211
333 BALANCE DISORDER 1821 0.0210
334 SQUAMOUS CELL CARCINOMA OF SKIN 127 0.0210
335 IMMUNODEFICIENCY 313 0.0210
336 INFUSION SITE ERYTHEMA 177 0.0210
337 POST PROCEDURAL INFECTION 170 0.0209
338 DELIRIUM 721 0.0208
339 BASAL CELL CARCINOMA 324 0.0207
340 BACK INJURY 225 0.0207
341 MUSCLE STRAIN 178 0.0206
342 GENERAL PHYSICAL HEALTH DETERIORATION 2378 0.0205
343 FULL BLOOD COUNT DECREASED 414 0.0205
344 HEART RATE INCREASED 2028 0.0204
345 RECTAL HAEMORRHAGE 878 0.0204
346 NEPHROLITHIASIS 931 0.0203
347 FALL 6755 0.0203
348 DRY THROAT 206 0.0202
349 OEDEMA PERIPHERAL 2469 0.0202
350 SINUS HEADACHE 120 0.0202
351 FISTULA 227 0.0202
352 POLLAKIURIA 842 0.0202
353 GLUCOSE TOLERANCE IMPAIRED 119 0.0201
354 SKIN WARM 117 0.0201
355 WEIGHT INCREASED 4474 0.0200
356 WEIGHT DECREASED 5574 0.0199
357 HYPERLIPIDAEMIA 238 0.0199
358 URINARY TRACT INFECTION 3395 0.0199
359 LIVER DISORDER 874 0.0197
360 ECCHYMOSIS 135 0.0197
361 PIGMENTATION DISORDER 121 0.0196
362 OROPHARYNGEAL PAIN 1811 0.0195
363 INJURY 1374 0.0195
364 BLOOD URINE PRESENT 371 0.0195
365 MOUTH ULCERATION 411 0.0195
366 CONCOMITANT DISEASE AGGRAVATED 120 0.0194
367 AMNESIA 1260 0.0193
368 MYASTHENIA GRAVIS 156 0.0193
369 ASTHENIA 7250 0.0193
370 ABDOMINAL PAIN UPPER 3949 0.0192
371 GASTROINTESTINAL PAIN 211 0.0192
372 BLOOD ALBUMIN DECREASED 152 0.0191
373 HAIR COLOUR CHANGES 238 0.0191
374 NEURALGIA 464 0.0191
375 HAIR DISORDER 157 0.0190
376 GASTROINTESTINAL DISORDER 1706 0.0190
377 HEAD DISCOMFORT 337 0.0190
378 BLADDER DISORDER 189 0.0190
379 FLATULENCE 1078 0.0190
380 TENDONITIS 294 0.0190
381 HYPERTENSION 4018 0.0189
382 FATIGUE 14767 0.0189
383 PLATELET COUNT INCREASED 247 0.0189
384 MOVEMENT DISORDER 608 0.0189
385 TENDERNESS 197 0.0189
386 CONSTIPATION 4120 0.0189
387 NASAL CONGESTION 1109 0.0189
388 HERPES ZOSTER 1082 0.0188
389 COUGH 5276 0.0188
390 PARAESTHESIA 2955 0.0188
391 FLANK PAIN 176 0.0188
392 BLOOD SODIUM DECREASED 353 0.0187
393 FEELING COLD 521 0.0187
394 MYALGIA 3180 0.0187
395 MEMORY IMPAIRMENT 2560 0.0186
396 RHINORRHOEA 1202 0.0186
397 BREAST PAIN 198 0.0185
398 EAR DISCOMFORT 190 0.0185
399 TENDON PAIN 140 0.0185
400 SMALL INTESTINAL OBSTRUCTION 227 0.0184
401 ORAL HERPES 359 0.0184
402 HYPERAESTHESIA 151 0.0184
403 OCULAR DISCOMFORT 206 0.0183
404 GOUT 329 0.0183
405 DECREASED INTEREST 108 0.0183
406 DYSPHONIA 1071 0.0183
407 LACERATION 172 0.0183
408 DECREASED APPETITE 4243 0.0182
409 MIDDLE INSOMNIA 341 0.0182
410 CHEST PAIN 3379 0.0182
411 FEELING HOT 1118 0.0182
412 FRACTURE 345 0.0182
413 NASAL DRYNESS 114 0.0182
414 INFLUENZA 2026 0.0181
415 INFUSION SITE PAIN 234 0.0181
416 ULCER 288 0.0181
417 TENDON DISORDER 118 0.0181
418 VIRAL INFECTION 602 0.0181
419 MULTIPLE FRACTURES 297 0.0181
420 GASTROENTERITIS VIRAL 326 0.0180
421 SLEEP APNOEA SYNDROME 344 0.0180
422 IMMUNE SYSTEM DISORDER 237 0.0180
423 ORAL CANDIDIASIS 236 0.0179
424 HAEMATOCRIT DECREASED 355 0.0179
425 OSTEOMYELITIS 324 0.0179
426 NEPHROPATHY 167 0.0179
427 RESPIRATORY TRACT CONGESTION 284 0.0179
428 PNEUMONIA 5768 0.0178
429 IMMUNOSUPPRESSION 157 0.0178
430 RESPIRATORY DISORDER 531 0.0177
431 WHITE BLOOD CELL COUNT INCREASED 679 0.0177
432 DRUG SPECIFIC ANTIBODY PRESENT 115 0.0177
433 ILL-DEFINED DISORDER 1074 0.0177
434 PHARYNGITIS STREPTOCOCCAL 191 0.0176
435 HYDRONEPHROSIS 132 0.0176
436 ABDOMINAL DISTENSION 1838 0.0176
437 HERNIA 340 0.0176
438 PHARYNGITIS 218 0.0176
439 BLOOD PRESSURE ABNORMAL 349 0.0175
440 THERAPY NON-RESPONDER 789 0.0175
441 WHITE BLOOD CELL COUNT ABNORMAL 112 0.0175
442 APPETITE DISORDER 116 0.0175
443 LIVER FUNCTION TEST INCREASED 375 0.0174
444 APHONIA 243 0.0174
445 EYE PAIN 982 0.0174
446 BODY TEMPERATURE INCREASED 355 0.0174
447 MUSCLE SPASTICITY 213 0.0173
448 MIGRAINE 1653 0.0173
449 FURUNCLE 137 0.0173
450 BLOOD THYROID STIMULATING HORMONE INCREASED 159 0.0173
451 MYOSITIS 155 0.0173
452 RENAL PAIN 183 0.0172
453 LOCAL SWELLING 301 0.0172
454 RHINITIS 139 0.0172
455 EATING DISORDER 367 0.0172
456 SCAB 196 0.0172
457 ATELECTASIS 166 0.0172
458 PAIN 10540 0.0171
459 INFECTION 2482 0.0171
460 LABORATORY TEST ABNORMAL 506 0.0171
461 APPENDICITIS 160 0.0171
462 DRY EYE 855 0.0171
463 MUSCLE ATROPHY 217 0.0171
464 ABDOMINAL PAIN 3975 0.0171
465 SKIN DISORDER 568 0.0170
466 BONE LOSS 255 0.0169
467 HEAD INJURY 534 0.0169
468 CARDIAC FLUTTER 109 0.0168
469 URINARY INCONTINENCE 499 0.0168
470 DERMATITIS CONTACT 192 0.0168
471 INSOMNIA 4476 0.0168
472 CELLULITIS 846 0.0168
473 CROHN'S DISEASE 115 0.0168
474 LACRIMATION INCREASED 506 0.0167
475 DISABILITY 331 0.0167
476 ATRIAL FIBRILLATION 1630 0.0167
477 MALNUTRITION 187 0.0167
478 CLOSTRIDIUM DIFFICILE COLITIS 177 0.0167
479 BLOOD COUNT ABNORMAL 252 0.0166
480 MITRAL VALVE INCOMPETENCE 188 0.0166
481 PNEUMOTHORAX 263 0.0166
482 TONGUE DISORDER 120 0.0166
483 CARDIAC MURMUR 143 0.0165
484 GASTROENTERITIS 241 0.0165
485 FAECES DISCOLOURED 358 0.0165
486 CONDITION AGGRAVATED 5019 0.0165
487 VITREOUS FLOATERS 162 0.0165
488 EYE INFLAMMATION 157 0.0164
489 ORAL DISCOMFORT 228 0.0164
490 CONCUSSION 127 0.0164
491 MATERNAL EXPOSURE DURING PREGNANCY 1461 0.0164
492 SKIN LESION 449 0.0164
493 SKIN INFECTION 183 0.0163
494 RASH PRURITIC 884 0.0163
495 OROPHARYNGEAL DISCOMFORT 147 0.0163
496 POST PROCEDURAL COMPLICATION 312 0.0162
497 MUSCLE TIGHTNESS 263 0.0162
498 NERVE INJURY 180 0.0162
499 DIZZINESS 8074 0.0162
500 DIARRHOEA 10422 0.0161
501 IRON DEFICIENCY ANAEMIA 149 0.0161
502 MUSCULOSKELETAL DISORDER 306 0.0161
503 TREATMENT FAILURE 1326 0.0160
504 KIDNEY INFECTION 314 0.0160
505 POOR QUALITY SLEEP 344 0.0160
506 WHITE BLOOD CELL COUNT DECREASED 1732 0.0160
507 HYPERSOMNIA 458 0.0160
508 HAEMOGLOBIN DECREASED 1640 0.0160
509 VASCULITIS 186 0.0160
510 GASTRITIS 420 0.0159
511 HYPOMAGNESAEMIA 222 0.0159
512 CHOLELITHIASIS 522 0.0159
513 BLOOD POTASSIUM INCREASED 258 0.0159
514 LOW DENSITY LIPOPROTEIN INCREASED 123 0.0159
515 INITIAL INSOMNIA 163 0.0159
516 PHOTOPHOBIA 298 0.0158
517 BEDRIDDEN 208 0.0158
518 INCONTINENCE 167 0.0158
519 PREGNANCY 316 0.0158
520 HYPOPHAGIA 403 0.0157
521 CONFUSIONAL STATE 2536 0.0157
522 HEPATIC STEATOSIS 292 0.0157
523 EMPHYSEMA 158 0.0156
524 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 817 0.0156
525 AGEUSIA 390 0.0156
526 CHILLS 1830 0.0156
527 BURNING SENSATION 1093 0.0156
528 NEUROPATHY PERIPHERAL 1477 0.0155
529 RETCHING 331 0.0155
530 FLUSHING 1578 0.0155
531 DIARRHOEA HAEMORRHAGIC 145 0.0155
532 DYSURIA 570 0.0155
533 SQUAMOUS CELL CARCINOMA 145 0.0154
534 EYE DISCHARGE 160 0.0154
535 TENDON RUPTURE 190 0.0154
536 NERVOUSNESS 804 0.0154
537 PALPITATIONS 1793 0.0153
538 COLITIS 579 0.0153
539 TROPONIN INCREASED 116 0.0152
540 BACTERIAL INFECTION 284 0.0152
541 DECUBITUS ULCER 124 0.0152
542 THROAT IRRITATION 680 0.0151
543 CHROMATURIA 342 0.0151
544 HEADACHE 9476 0.0151
545 BREAST CANCER METASTATIC 162 0.0151
546 SKIN DISCOLOURATION 691 0.0150
547 SKIN ULCER 388 0.0150
548 INTESTINAL OBSTRUCTION 565 0.0150
549 ABSCESS 239 0.0150
550 ATAXIA 177 0.0149
551 GLOMERULAR FILTRATION RATE DECREASED 183 0.0149
552 FLUID RETENTION 757 0.0149
553 CARDIOMEGALY 183 0.0149
554 PERIPHERAL COLDNESS 204 0.0148
555 UROSEPSIS 137 0.0148
556 RESTLESS LEGS SYNDROME 269 0.0148
557 FUNGAL INFECTION 493 0.0148
558 TRANSIENT ISCHAEMIC ATTACK 499 0.0148
559 COELIAC DISEASE 145 0.0148
560 ERUCTATION 286 0.0148
561 PROCEDURAL PAIN 408 0.0147
562 MUSCLE DISORDER 119 0.0147
563 MALAISE 6444 0.0147
564 CANDIDA INFECTION 248 0.0147
565 FEEDING DISORDER 297 0.0146
566 INFLUENZA LIKE ILLNESS 1204 0.0146
567 OVARIAN CYST 146 0.0146
568 HYPOKINESIA 212 0.0146
569 LYMPHOCYTE COUNT DECREASED 258 0.0146
570 PULMONARY THROMBOSIS 159 0.0146
571 BLOOD PRESSURE DECREASED 968 0.0146
572 GASTRIC ULCER 276 0.0145
573 PSYCHOLOGICAL TRAUMA 125 0.0145
574 HYPOAESTHESIA ORAL 218 0.0144
575 QUALITY OF LIFE DECREASED 194 0.0144
576 DEHYDRATION 1928 0.0144
577 OFF LABEL USE 12637 0.0144
578 SUPRAVENTRICULAR TACHYCARDIA 138 0.0144
579 HYPERSENSITIVITY 2674 0.0144
580 DYSPNOEA 8123 0.0143
581 PRURITUS GENERALISED 310 0.0143
582 PLASMA CELL MYELOMA 559 0.0143
583 SCRATCH 151 0.0143
584 VOMITING 6729 0.0143
585 ABASIA 353 0.0143
586 TEMPERATURE INTOLERANCE 147 0.0142
587 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1013 0.0142
588 METASTASES TO LUNG 164 0.0142
589 ACTIVITIES OF DAILY LIVING IMPAIRED 281 0.0142
590 CHRONIC KIDNEY DISEASE 1078 0.0142
591 URINE OUTPUT DECREASED 124 0.0142
592 SPLENOMEGALY 166 0.0142
593 EPILEPSY 433 0.0142
594 EYE HAEMORRHAGE 189 0.0141
595 OESOPHAGITIS 154 0.0141
596 PYREXIA 4868 0.0141
597 NAUSEA 11112 0.0140
598 UVEITIS 190 0.0140
599 STAPHYLOCOCCAL INFECTION 462 0.0140
600 DECREASED ACTIVITY 151 0.0140
601 EYE DISORDER 458 0.0139
602 LUNG INFILTRATION 123 0.0139
603 DYSGEUSIA 1034 0.0139
604 MADAROSIS 161 0.0139
605 URTICARIA 2320 0.0138
606 BLOOD CREATININE INCREASED 899 0.0138
607 CHEST DISCOMFORT 1409 0.0137
608 TINNITUS 632 0.0137
609 TOOTH LOSS 284 0.0137
610 ASPIRATION 150 0.0137
611 SNEEZING 307 0.0137
612 ANAEMIA 2606 0.0136
613 BRAIN FOG 214 0.0136
614 HYPOTHYROIDISM 436 0.0136
615 THROMBOSIS 1096 0.0136
616 EPISTAXIS 1014 0.0135
617 INJECTION SITE BRUISING 1076 0.0135
618 CONJUNCTIVITIS 250 0.0135
619 PRODUCT USE ISSUE 2527 0.0134
620 EOSINOPHIL COUNT INCREASED 112 0.0134
621 FEELING ABNORMAL 3220 0.0134
622 LYMPHADENOPATHY 475 0.0134
623 PRURITUS 5149 0.0134
624 BLOOD ALKALINE PHOSPHATASE INCREASED 331 0.0133
625 CENTRAL NERVOUS SYSTEM LESION 183 0.0133
626 SLUGGISHNESS 135 0.0132
627 GALLBLADDER DISORDER 236 0.0132
628 DEPRESSION 3005 0.0132
629 ANXIETY 3751 0.0132
630 SARS-COV-2 TEST POSITIVE 174 0.0132
631 SENSORY DISTURBANCE 211 0.0131
632 VISUAL IMPAIRMENT 1629 0.0131
633 DIPLOPIA 341 0.0131
634 END STAGE RENAL DISEASE 239 0.0131
635 SKIN CANCER 282 0.0131
636 LUNG INFECTION 202 0.0130
637 CORONARY ARTERY OCCLUSION 178 0.0130
638 ORTHOSTATIC HYPOTENSION 226 0.0130
639 PLEURAL EFFUSION 788 0.0129
640 VAGINAL DISCHARGE 131 0.0129
641 PETECHIAE 135 0.0129
642 FEELING JITTERY 246 0.0129
643 RASH MACULAR 451 0.0129
644 SKIN HAEMORRHAGE 191 0.0129
645 THERAPEUTIC RESPONSE SHORTENED 427 0.0129
646 VERTIGO 784 0.0129
647 VISION BLURRED 1765 0.0128
648 INJECTION SITE HAEMATOMA 186 0.0128
649 NEUTROPHIL COUNT INCREASED 131 0.0128
650 BLOOD UREA INCREASED 214 0.0128
651 CHOKING 249 0.0128
652 METASTASES TO LIVER 224 0.0127
653 PRODUCT DISTRIBUTION ISSUE 118 0.0127
654 NEOPLASM 146 0.0127
655 SCAR 217 0.0127
656 RASH 5519 0.0126
657 PNEUMONIA BACTERIAL 116 0.0126
658 EXPOSURE DURING PREGNANCY 782 0.0126
659 ABDOMINAL PAIN LOWER 318 0.0126
660 OSTEONECROSIS 411 0.0125
661 SKIN REACTION 176 0.0125
662 PERICARDIAL EFFUSION 288 0.0124
663 ADVERSE DRUG REACTION 1118 0.0124
664 INTENTIONAL DOSE OMISSION 354 0.0124
665 ACCIDENT 148 0.0124
666 MALIGNANT MELANOMA 166 0.0124
667 COVID-19 2171 0.0124
668 HAEMOPTYSIS 344 0.0123
669 THIRST 220 0.0123
670 DEFORMITY 115 0.0123
671 HAEMATOMA 318 0.0123
672 IMPAIRED DRIVING ABILITY 139 0.0122
673 DYSPHAGIA 1159 0.0122
674 CRYING 443 0.0122
675 GINGIVAL BLEEDING 166 0.0121
676 PHOTOSENSITIVITY REACTION 200 0.0121
677 SWELLING FACE 788 0.0121
678 SPINAL OPERATION 149 0.0121
679 DEPRESSED MOOD 639 0.0121
680 INJECTION SITE EXTRAVASATION 149 0.0121
681 EYE SWELLING 449 0.0121
682 IMPAIRED WORK ABILITY 258 0.0121
683 RENAL DISORDER 560 0.0120
684 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2165 0.0120
685 TREMOR 1991 0.0120
686 PULMONARY CONGESTION 158 0.0120
687 BLINDNESS UNILATERAL 169 0.0120
688 CORONARY ARTERY DISEASE 362 0.0119
689 EYE IRRITATION 687 0.0119
690 MUSCLE TWITCHING 275 0.0119
691 RASH PAPULAR 267 0.0119
692 DRUG-INDUCED LIVER INJURY 373 0.0119
693 ERYTHEMA 2443 0.0119
694 DEMENTIA 331 0.0118
695 ANKYLOSING SPONDYLITIS 156 0.0118
696 ELECTROLYTE IMBALANCE 137 0.0118
697 PULMONARY OEDEMA 528 0.0118
698 LETHARGY 678 0.0118
699 THERAPY CESSATION 604 0.0118
700 PRESYNCOPE 286 0.0118
701 OCULAR HYPERAEMIA 557 0.0117
702 THINKING ABNORMAL 218 0.0117
703 INJECTION SITE DISCOLOURATION 146 0.0117
704 ECONOMIC PROBLEM 177 0.0117
705 VENTRICULAR EXTRASYSTOLES 121 0.0116
706 PELVIC PAIN 211 0.0116
707 PNEUMONIA ASPIRATION 290 0.0116
708 FEAR 312 0.0116
709 HYPOTENSION 2325 0.0116
710 INCREASED APPETITE 221 0.0116
711 EYE PRURITUS 387 0.0115
712 INSURANCE ISSUE 176 0.0115
713 PLATELET COUNT DECREASED 1226 0.0115
714 INJECTION SITE ERYTHEMA 1426 0.0115
715 CHOLECYSTECTOMY 131 0.0115
716 GASTRIC DISORDER 393 0.0114
717 HYPERHIDROSIS 1468 0.0114
718 HYPOACUSIS 489 0.0113
719 REBOUND EFFECT 128 0.0113
720 ADRENAL INSUFFICIENCY 137 0.0113
721 NEOPLASM PROGRESSION 392 0.0113
722 HUNGER 157 0.0113
723 BLOOD TRIGLYCERIDES INCREASED 199 0.0113
724 PRODUCT USE COMPLAINT 177 0.0112
725 APHASIA 339 0.0112
726 SOMNOLENCE 2258 0.0112
727 ANHEDONIA 293 0.0111
728 RENAL IMPAIRMENT 936 0.0111
729 RASH ERYTHEMATOUS 531 0.0111
730 SKIN FISSURES 216 0.0110
731 HYPOKALAEMIA 509 0.0110
732 EYELID PTOSIS 112 0.0110
733 PRODUCT DOSE OMISSION IN ERROR 311 0.0110
734 ARRHYTHMIA 518 0.0109
735 DEAFNESS 286 0.0109
736 CHOLECYSTITIS 130 0.0109
737 SPEECH DISORDER 569 0.0108
738 PARALYSIS 155 0.0108
739 TRANSFUSION 113 0.0108
740 ILLNESS 1111 0.0108
741 THROAT TIGHTNESS 291 0.0107
742 EYELID OEDEMA 125 0.0107
743 INJECTION SITE PRURITUS 719 0.0107
744 DYSARTHRIA 404 0.0107
745 RENAL FAILURE 1425 0.0107
746 CARDIAC DISORDER 996 0.0106
747 IMPAIRED QUALITY OF LIFE 153 0.0106
748 POLYNEUROPATHY 127 0.0106
749 UNDERDOSE 770 0.0105
750 SYNCOPE 1055 0.0105
751 COGNITIVE DISORDER 490 0.0105
752 HEMIPARESIS 177 0.0104
753 SEPSIS 1164 0.0104
754 PULMONARY HYPERTENSION 217 0.0104
755 INJECTION SITE HAEMORRHAGE 831 0.0104
756 URINARY RETENTION 346 0.0104
757 DEEP VEIN THROMBOSIS 673 0.0103
758 TACHYCARDIA 920 0.0103
759 INTESTINAL PERFORATION 116 0.0103
760 DERMATITIS 216 0.0103
761 PALLOR 280 0.0103
762 VISUAL ACUITY REDUCED 341 0.0103
763 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 727 0.0102
764 PANCREATITIS 540 0.0102
765 PULMONARY EMBOLISM 970 0.0102
766 LIP SWELLING 339 0.0102
767 DRY SKIN 1355 0.0101
768 DIABETES MELLITUS 773 0.0101
769 THYROID CANCER 122 0.0101
770 COLD SWEAT 178 0.0101
771 HYPERTHYROIDISM 146 0.0101
772 LIVER FUNCTION TEST ABNORMAL 292 0.0100
773 COORDINATION ABNORMAL 140 0.0100
774 ACUTE RESPIRATORY FAILURE 192 0.0100
775 RASH GENERALISED 258 0.0100
776 PRODUCT ADMINISTRATION ERROR 199 0.0098
777 ADVERSE EVENT 905 0.0098
778 APATHY 143 0.0098
779 COAGULOPATHY 163 0.0098
780 CARDIAC FAILURE CONGESTIVE 785 0.0098
781 EOSINOPHILIA 171 0.0097
782 SURGERY 571 0.0097
783 INCORRECT PRODUCT ADMINISTRATION DURATION 210 0.0097
784 INJECTION SITE RASH 297 0.0097
785 ANOSMIA 140 0.0097
786 DISTURBANCE IN ATTENTION 521 0.0097
787 PRODUCT AVAILABILITY ISSUE 219 0.0096
788 PRODUCT SUBSTITUTION ISSUE 553 0.0096
789 LOSS OF CONSCIOUSNESS 1226 0.0096
790 PHARYNGEAL OEDEMA 147 0.0095
791 THERAPEUTIC RESPONSE DECREASED 579 0.0095
792 THERAPEUTIC RESPONSE UNEXPECTED 425 0.0095
793 GENERALISED OEDEMA 117 0.0094
794 INTRAOCULAR PRESSURE INCREASED 120 0.0094
795 SWOLLEN TONGUE 293 0.0094
796 INJECTION SITE PAIN 2877 0.0094
797 POST PROCEDURAL HAEMORRHAGE 109 0.0094
798 DEVICE RELATED INFECTION 144 0.0093
799 ANGINA PECTORIS 268 0.0093
800 CARDIOGENIC SHOCK 134 0.0093
801 BRONCHOSPASM 133 0.0093
802 LEUKOPENIA 466 0.0093
803 DISORIENTATION 368 0.0093
804 COLON CANCER 138 0.0093
805 ACUTE MYOCARDIAL INFARCTION 273 0.0092
806 NEUTROPHIL COUNT DECREASED 377 0.0092
807 PRODUCT USE IN UNAPPROVED INDICATION 2285 0.0092
808 ADVERSE REACTION 122 0.0092
809 DRUG EFFECT INCOMPLETE 334 0.0092
810 DRUG DOSE OMISSION 1512 0.0091
811 INTENTIONAL PRODUCT MISUSE 799 0.0091
812 MEDICATION ERROR 502 0.0090
813 HEPATITIS 231 0.0090
814 IMPAIRED GASTRIC EMPTYING 123 0.0090
815 DERMATITIS ALLERGIC 113 0.0090
816 PSORIASIS 1171 0.0090
817 MENTAL IMPAIRMENT 217 0.0089
818 ABNORMAL DREAMS 247 0.0089
819 HAEMATURIA 306 0.0089
820 HYPOXIA 314 0.0089
821 INJECTION SITE MASS 329 0.0089
822 MALIGNANT NEOPLASM PROGRESSION 901 0.0088
823 SKIN EXFOLIATION 741 0.0088
824 LEUKOCYTOSIS 158 0.0087
825 THERAPY INTERRUPTED 622 0.0087
826 METASTASES TO CENTRAL NERVOUS SYSTEM 112 0.0087
827 PANIC ATTACK 316 0.0087
828 INJECTION SITE URTICARIA 212 0.0086
829 HYPONATRAEMIA 486 0.0086
830 LYMPHOPENIA 122 0.0086
831 MENTAL STATUS CHANGES 239 0.0086
832 PNEUMONITIS 234 0.0086
833 PRODUCT DOSE OMISSION 561 0.0086
834 TREATMENT NONCOMPLIANCE 470 0.0086
835 INJECTION SITE REACTION 591 0.0086
836 WRONG TECHNIQUE IN DRUG USAGE PROCESS 311 0.0086
837 BRADYCARDIA 454 0.0086
838 INJECTION SITE SWELLING 653 0.0085
839 PRODUCT DOSE OMISSION ISSUE 2493 0.0085
840 PAIN OF SKIN 228 0.0085
841 UNEVALUABLE EVENT 639 0.0084
842 INCORRECT DRUG ADMINISTRATION DURATION 235 0.0083
843 ECZEMA 437 0.0083
844 DYSKINESIA 338 0.0083
845 HAEMORRHAGE 865 0.0083
846 INTERNATIONAL NORMALISED RATIO INCREASED 235 0.0082
847 EMOTIONAL DISORDER 254 0.0082
848 DRUG INEFFECTIVE 10854 0.0082
849 UPPER GASTROINTESTINAL HAEMORRHAGE 137 0.0081
850 INJECTION SITE WARMTH 167 0.0081
851 SUBDURAL HAEMATOMA 116 0.0081
852 DRUG EFFECT LESS THAN EXPECTED 120 0.0081
853 RESTLESSNESS 295 0.0081
854 EXPIRED PRODUCT ADMINISTERED 267 0.0080
855 MOOD SWINGS 255 0.0080
856 HALLUCINATION 602 0.0080
857 CARDIOMYOPATHY 118 0.0080
858 ASPARTATE AMINOTRANSFERASE INCREASED 424 0.0080
859 MULTIPLE SCLEROSIS RELAPSE 546 0.0080
860 ACNE 598 0.0079
861 MOOD ALTERED 215 0.0079
862 DIABETES MELLITUS INADEQUATE CONTROL 139 0.0078
863 ASCITES 230 0.0078
864 IRRITABILITY 468 0.0078
865 INCORRECT DOSE ADMINISTERED 1775 0.0078
866 VAGINAL HAEMORRHAGE 337 0.0078
867 LYMPHOMA 120 0.0078
868 BLINDNESS 315 0.0077
869 GASTROINTESTINAL HAEMORRHAGE 646 0.0077
870 CIRCULATORY COLLAPSE 131 0.0077
871 ELECTROCARDIOGRAM QT PROLONGED 276 0.0077
872 ALANINE AMINOTRANSFERASE INCREASED 470 0.0076
873 GAMMA-GLUTAMYLTRANSFERASE INCREASED 169 0.0076
874 ACUTE KIDNEY INJURY 1167 0.0076
875 BLOOD GLUCOSE ABNORMAL 139 0.0075
876 MULTIPLE SCLEROSIS 359 0.0075
877 MUCOSAL INFLAMMATION 196 0.0075
878 PREMATURE DELIVERY 119 0.0075
879 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 410 0.0075
880 SEIZURE 861 0.0074
881 NIGHTMARE 257 0.0074
882 DEPRESSED LEVEL OF CONSCIOUSNESS 293 0.0074
883 DISEASE RECURRENCE 351 0.0074
884 GENERALISED TONIC-CLONIC SEIZURE 122 0.0074
885 DEVICE FAILURE 112 0.0073
886 DRUG EFFECT DECREASED 395 0.0073
887 HALLUCINATION, VISUAL 154 0.0073
888 DRUG PRESCRIBING ERROR 140 0.0073
889 FEBRILE NEUTROPENIA 483 0.0073
890 EJECTION FRACTION DECREASED 113 0.0073
891 HOSPITALISATION 1114 0.0072
892 CEREBROVASCULAR ACCIDENT 1228 0.0072
893 RENAL FAILURE ACUTE 307 0.0072
894 NEUTROPENIA 983 0.0072
895 BLOOD BILIRUBIN INCREASED 195 0.0072
896 CARDIAC FAILURE 578 0.0072
897 RESPIRATORY DISTRESS 197 0.0071
898 PRODUCT QUALITY ISSUE 969 0.0071
899 PANCYTOPENIA 394 0.0070
900 PSYCHOMOTOR HYPERACTIVITY 117 0.0070
901 RESPIRATORY FAILURE 514 0.0070
902 ANGER 236 0.0070
903 UNRESPONSIVE TO STIMULI 179 0.0069
904 COMA 330 0.0069
905 LUNG NEOPLASM MALIGNANT 284 0.0069
906 BLOOD GLUCOSE INCREASED 1289 0.0068
907 TRANSAMINASES INCREASED 152 0.0068
908 BLOOD GLUCOSE DECREASED 328 0.0068
909 PRODUCT PRESCRIBING ERROR 162 0.0068
910 APPLICATION SITE ERYTHEMA 178 0.0068
911 HYPERGLYCAEMIA 247 0.0068
912 NEOPLASM MALIGNANT 452 0.0068
913 RENAL INJURY 201 0.0068
914 NERVOUS SYSTEM DISORDER 210 0.0067
915 THROMBOCYTOPENIA 749 0.0067
916 HYPOGLYCAEMIA 321 0.0066
917 MENTAL DISORDER 285 0.0065
918 PRODUCT PHYSICAL ISSUE 132 0.0065
919 NEEDLE ISSUE 190 0.0065
920 DRUG INTERACTION 1031 0.0065
921 DISEASE PROGRESSION 766 0.0065
922 ERECTILE DYSFUNCTION 166 0.0065
923 AGITATION 472 0.0064
924 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 149 0.0064
925 MULTIPLE ORGAN DYSFUNCTION SYNDROME 180 0.0063
926 PROTEINURIA 120 0.0063
927 APPLICATION SITE PRURITUS 143 0.0063
928 HEPATOTOXICITY 140 0.0063
929 SEDATION 162 0.0062
930 APPLICATION SITE PAIN 136 0.0062
931 CARDIO-RESPIRATORY ARREST 255 0.0061
932 TUBULOINTERSTITIAL NEPHRITIS 114 0.0061
933 INTENTIONAL DRUG MISUSE 127 0.0061
934 HYPERKALAEMIA 212 0.0060
935 INTERSTITIAL LUNG DISEASE 290 0.0060
936 CARDIOVASCULAR DISORDER 152 0.0060
937 BLOOD CREATINE PHOSPHOKINASE INCREASED 171 0.0059
938 BREAST CANCER 550 0.0059
939 RASH MACULO-PAPULAR 131 0.0059
940 ABNORMAL BEHAVIOUR 233 0.0059
941 METABOLIC ACIDOSIS 187 0.0058
942 SEPTIC SHOCK 254 0.0058
943 SKIN BURNING SENSATION 416 0.0058
944 SKIN IRRITATION 266 0.0058
945 MYOCARDIAL INFARCTION 996 0.0057
946 WITHDRAWAL SYNDROME 239 0.0057
947 CONVULSION 322 0.0056
948 BREAST CANCER FEMALE 150 0.0056
949 DRUG ADMINISTRATION ERROR 169 0.0055
950 MELAENA 121 0.0055
951 ENCEPHALOPATHY 135 0.0055
952 JAUNDICE 143 0.0053
953 PRODUCT PRESCRIBING ISSUE 114 0.0052
954 CARDIAC ARREST 431 0.0052
955 PREMATURE BABY 157 0.0052
956 DEVICE MALFUNCTION 366 0.0052
957 HAEMATEMESIS 132 0.0052
958 DEVICE ISSUE 467 0.0052
959 EMOTIONAL DISTRESS 627 0.0052
960 PANCREATITIS ACUTE 116 0.0052
961 SUICIDAL IDEATION 469 0.0051
962 ANAPHYLACTIC REACTION 279 0.0050
963 ACCIDENTAL OVERDOSE 183 0.0050
964 EXTRA DOSE ADMINISTERED 199 0.0049
965 CEREBRAL HAEMORRHAGE 175 0.0049
966 RHABDOMYOLYSIS 203 0.0049
967 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 982 0.0048
968 SHOCK 111 0.0048
969 GLYCOSYLATED HAEMOGLOBIN INCREASED 119 0.0047
970 PHARMACEUTICAL PRODUCT COMPLAINT 121 0.0047
971 DEATH 4008 0.0046
972 HEPATIC FAILURE 130 0.0043
973 DEVICE DISLOCATION 178 0.0041
974 TOXICITY TO VARIOUS AGENTS 684 0.0041
975 PSYCHOTIC DISORDER 111 0.0038
976 AGGRESSION 181 0.0036
977 DERMATITIS ATOPIC 188 0.0036
978 FOETAL EXPOSURE DURING PREGNANCY 289 0.0036
979 ABORTION SPONTANEOUS 140 0.0035
980 ANGIOEDEMA 154 0.0035
981 INCORRECT ROUTE OF DRUG ADMINISTRATION 118 0.0033
982 DEVICE BREAKAGE 134 0.0033
983 OVERDOSE 700 0.0032
984 DEVICE LEAKAGE 136 0.0031
985 PROSTATE CANCER 245 0.0030
986 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 130 0.0028
987 PRODUCT STORAGE ERROR 238 0.0027
988 INTENTIONAL OVERDOSE 166 0.0026
989 ACCIDENTAL EXPOSURE TO PRODUCT 264 0.0026
990 NO ADVERSE EVENT 438 0.0024
991 DRUG WITHDRAWAL SYNDROME 202 0.0023
992 SUICIDE ATTEMPT 123 0.0020
993 DRUG DEPENDENCE 140 0.0009